Faus & Moliner participates in the Pharmaceutical Law Course organized by CEFI

Lluís Alcover gives a presentation on Patient Support Programs and Jordi Faus addresses the legal challenges of advanced therapy medicinal products

Faus Moliner

In the “Pharmaceutical Law Course. Biomedicine, Medicines and Public Health ”organized by CEFI, Lluís Alcover has participated with a presentation on the regulation of observational studies with medicines for human use in which he has analized the new requirements provided in Royal Decree 957/2020 for this type of studies the legal regime applicable to patient support programs.

For his part, in his presentation on the Application of the Advanced Therapies Plan, Jordi Faus has exposed the main challenges and opportunities involved in the development of innovative therapies, as well as their practical application, and has addressed in depth the characteristics and challenges of the hospital exemption clauses.

Uso de cookies

Este sitio web utiliza cookies para que usted tenga la mejor experiencia de usuario. Si continúa navegando está dando su consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies, pinche el enlace para mayor información. ACEPTAR

Aviso de cookies